FORMATION AND REVERSE ACQUISITION OF MATINAS BIOPHARMA HOLDINGS - Summary of Changes in Capitalization (Details Textual) (USD $)
|
1 Months Ended | 2 Months Ended | 1 Months Ended | 2 Months Ended | 1 Months Ended | 2 Months Ended | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jul. 31, 2013
Herbert Conrad [Member]
|
Aug. 31, 2013
Private Placement [Member]
|
Aug. 31, 2013
Private Placement [Member]
Herbert Conrad [Member]
|
Aug. 31, 2013
Placement Agent [Member]
|
Aug. 31, 2013
Warrant Private Placement [Member]
Herbert Conrad [Member]
|
May 31, 2013
Formation Of Holdings [Member]
|
Aug. 31, 2013
Formation Of Holdings [Member]
|
May 31, 2013
Formation Of Holdings [Member]
Adam Stern And Entities Owned By Stern [Member]
|
Aug. 31, 2013
Formation Of Holdings [Member]
Adam Stern And Entities Owned By Stern [Member]
|
Aug. 31, 2013
Former preferred and common shareholders [Member]
|
Aug. 31, 2013
Former preferred and common shareholders [Member]
Common Stock [Member]
|
Aug. 31, 2013
Former preferred and common shareholders [Member]
Preferred Stock [Member]
|
Aug. 31, 2013
Unit Purchasers [Member]
|
Aug. 31, 2013
Aegis Capital Corp [Member]
|
Aug. 31, 2013
Aegis Capital Corp [Member]
Private Placement [Member]
|
||||||||||
Formation And Reverse Acquisition [Line Items] | ||||||||||||||||||||||||
Warrants Issued For Purchase Of Common Stock | 250,000 | 7,500,000 | [1] | 125,000 | 2,250,000 | 500,000 | 3,750,000 | 250,000 | 1,500,000 | [2] | 4,000,000 | [3] | 2,250,000 | |||||||||||
Proceeds from Issuance or Sale of Equity, Total | $ 15,000,000 | $ 250,000 | $ 375,000 | $ 15,000,000 | ||||||||||||||||||||
Merger Agreement, Number Of Shares Cancelled | 10,000,000 | 1,851,852 | ||||||||||||||||||||||
Stock Issued During Period, Shares, New Issues | 351,563 | 15,000,000 | [1] | 250,000 | 7,500,000 | 2,000,000 | 9,000,000 | [2] | 7,500,000 | [3] | ||||||||||||||
Aggregate Common Stock Holding Percentage | 47.70% | [1] | 28.50% | [2] | 23.80% | [3] | ||||||||||||||||||
|